-
Terranata Centella Alta Natura 45 Tablets ₦26,695.00 -
Oxil Plus Shampoo 120ml ₦660.00 -
-
COFORMIN 1MG TAB 15`S ₦2,042.00 -
OXIPOD 200MG TAB 10`S ₦3,309.50 -
-
ENCORATE 200ML SYP ₦2,676.25 -
ORAFLORA TABLET ₦951.75 -
-
Portwest (UK) – Obra Safety Sandal S1 ₦1,000.00 -
-
Combiflam Icyhot 35Gm Spray ₦2,719.00 -
BIOCILIN 500MG CAP 10`S ₦1,649.00 -
ETOLGIA MR TABLET 10 ₦4,696.25 -
Enzymedica Lacto Capsules 30s ₦40,992.00 -
-
DERMOZONE AWC LOTION 50ML ₦31,968.75 -
HiSmile Glostik Tooth Gloss ₦99,900.00 -
AB FLO SR 200MG TABLET ₦4,916.00 -
Kin Fresh Toothpaste 125ml ₦10,500.00
-
Hitica Tab SpecificationRequires Prescription (YES/NO)YesGenericsTicagrelorUsed ForBlood ClotHow it worksTicagrelor reversibly interacts with the platelet P2Y12 ADP-receptor to prevent signal transduction and platelet activation. Ticagrelor and its active metabolite are approximately equipotent.Hitica Tab Usage And SafetyDosageTicagrelorSide EffectsNeoplasms benign, malignant and unspecified (including cysts and polyps): Uncommon: Tumour bleedings, Blood and lymphatic system disorders: Very common: Blood disorder bleedings, Immune system disorders: Uncommon: Hypersensitivity including angioedemac, Metabolism and nutrition disorders: Very common: Hyperuricaemiad ; Common: Gout/Gouty Arthritis, Psychiatric disorders : Uncommon: ConfusionNervous system disorders : Common: Dizziness, Syncope, Headache ; Uncommon: Intracranial haemorrhage, Eye disorders : Uncommon: Eye haemorrhagee, Ear and labyrinth disorders : Common: Vertigo; Uncommon: Ear haemorrhageVascular disorders : Common: HypotensionRespiratory, thoracic and mediastinal disorders : Very common: Dyspnoea ; Common: Respiratory system bleedings.Drug InteractionsStrong CYP3A Inhibitors : Strong CYP3A inhibitors substantially increase ticagrelor exposure and so increase the risk ofdyspnea, bleeding, and other adverse events. Avoid use of strong inhibitors of CYP3A (e.g.,ketoconazole, itraconazole, voriconazole, clarithromycin, nefazodone, ritonavir, saquinavir, nelfinavir, indinavir, atazanavir and telithromycin).Strong CYP3A Inducers : Strong CYP3A inducers substantially reduce ticagrelor exposure and so decrease the efficacy of ticagrelor. Avoid use with strong inducers of CYP3A (e.g., rifampin, phenytoin, carbamazepine and phenobarbital).Aspirin : Use of Ticagrelor with aspirin maintenance doses above 100 mg reduced the effectiveness of ticagrelor.Simvastatin, Lovastatin : Ticagrelor increases serum concentrations of simvastatin and lovastatin because these drugs are metabolized by CYP3A4. Avoid simvastatin and lovastatin doses greater than 40 mg.Digoxin : Ticagrelor inhibits the P-glycoprotein transporter; monitor digoxin levels with initiation of or change in Ticagrelor therapy.IndicationTicagrelor is indicated to reduce the rate of:? Cardiovascular death? Myocardial infarction? Stroke in patients with acute coronary syndrome (ACS) or a history of myocardial infarction (MI)? Also reduces the rate of stent thrombosis in patients who have been stented for treatment of ACSWhen not to UseHistory of Intracranial Hemorrhage : Ticagrelor is contraindicated in patients with a history of intracranial hemorrhage (ICH) because of a high risk of recurrent ICH in this population.Active Bleeding : Ticagrelor is contraindicated in patients with active pathological bleeding such as peptic ulcer or intracranial hemorrhage.Hypersensitivity : Ticagrelor is contraindicated in patients with hypersensitivity (e.g., angioedema) to ticagrelor or : any component of the product.Severe Hepatic Impairment : Ticagrelor is contraindicated in patients with severe hepatic patients because of probable increase in exposure. Severe hepatic impairment increases the risk of bleeding because of reduced synthesis of coagulation proteins.Hitica Tab PrecautionsPrecautionDrugs that inhibit platelet function including Ticagrelor increase the risk of bleeding. If possible, manage bleeding without discontinuing Ticagrelor. Stopping Ticagrelor increases the risk of subsequent cardiovascular events.Hitica Tab WarningsWarning 1Patients treated with Ticagrelor may develop dyspnea. Dyspnea is usually mild to moderate in intensity and often resolves during continued treatment, but lead to drug discontinuation . If a patient develops new, prolonged, or worsened dyspnea that is determined to be related to Ticagrelor, no specific treatment is required; continue Ticagrelor without interruption if possible. In the case of intolerable dyspnea requiring discontinuation of Ticagrelor, consider prescribing another antiplatelet agent.Warning 2Discontinuation of Ticagrelor will increase the risk of myocardial infarction, stroke, and death. If Ticagrelor must be temporarily discontinued (e.g., to treat bleeding or for significant surgery), restart it as soon as possible. When possible, interrupt therapy with Ticagrelor for five days prior to surgery that has a major risk of bleeding. Resume Ticagrelor as soon as hemostasis is achieved.Warning 3Only limited information is available for use in patients with moderate hepatic impairment. Dose adjustments are not recommended but ticagrelor should be used with caution.Hitica Tab Additional InformationPregnancy categoryAlways consult your physician before using any medicine.Storage (YES/NO)Store this medicine at room temperature, away from direct light and heat.Hitica Tab 60Mg 10S
₦3,734.00 -
Hitica Tab SpecificationRequires Prescription (YES/NO)YesGenericsTicagrelorUsed ForBlood ClotHow it worksTicagrelor reversibly interacts with the platelet P2Y12 ADP-receptor to prevent signal transduction and platelet activation. Ticagrelor and its active metabolite are approximately equipotent.Hitica Tab Usage And SafetyDosageTicagrelorSide EffectsNeoplasms benign, malignant and unspecified (including cysts and polyps): Uncommon: Tumour bleedings, Blood and lymphatic system disorders: Very common: Blood disorder bleedings, Immune system disorders: Uncommon: Hypersensitivity including angioedemac, Metabolism and nutrition disorders: Very common: Hyperuricaemiad ; Common: Gout/Gouty Arthritis, Psychiatric disorders : Uncommon: ConfusionNervous system disorders : Common: Dizziness, Syncope, Headache ; Uncommon: Intracranial haemorrhage, Eye disorders : Uncommon: Eye haemorrhagee, Ear and labyrinth disorders : Common: Vertigo; Uncommon: Ear haemorrhageVascular disorders : Common: HypotensionRespiratory, thoracic and mediastinal disorders : Very common: Dyspnoea ; Common: Respiratory system bleedings.Drug InteractionsStrong CYP3A Inhibitors : Strong CYP3A inhibitors substantially increase ticagrelor exposure and so increase the risk ofdyspnea, bleeding, and other adverse events. Avoid use of strong inhibitors of CYP3A (e.g.,ketoconazole, itraconazole, voriconazole, clarithromycin, nefazodone, ritonavir, saquinavir, nelfinavir, indinavir, atazanavir and telithromycin).Strong CYP3A Inducers : Strong CYP3A inducers substantially reduce ticagrelor exposure and so decrease the efficacy of ticagrelor. Avoid use with strong inducers of CYP3A (e.g., rifampin, phenytoin, carbamazepine and phenobarbital).Aspirin : Use of Ticagrelor with aspirin maintenance doses above 100 mg reduced the effectiveness of ticagrelor.Simvastatin, Lovastatin : Ticagrelor increases serum concentrations of simvastatin and lovastatin because these drugs are metabolized by CYP3A4. Avoid simvastatin and lovastatin doses greater than 40 mg.Digoxin : Ticagrelor inhibits the P-glycoprotein transporter; monitor digoxin levels with initiation of or change in Ticagrelor therapy.IndicationTicagrelor is indicated to reduce the rate of:? Cardiovascular death? Myocardial infarction? Stroke in patients with acute coronary syndrome (ACS) or a history of myocardial infarction (MI)? Also reduces the rate of stent thrombosis in patients who have been stented for treatment of ACSWhen not to UseHistory of Intracranial Hemorrhage : Ticagrelor is contraindicated in patients with a history of intracranial hemorrhage (ICH) because of a high risk of recurrent ICH in this population.Active Bleeding : Ticagrelor is contraindicated in patients with active pathological bleeding such as peptic ulcer or intracranial hemorrhage.Hypersensitivity : Ticagrelor is contraindicated in patients with hypersensitivity (e.g., angioedema) to ticagrelor or : any component of the product.Severe Hepatic Impairment : Ticagrelor is contraindicated in patients with severe hepatic patients because of probable increase in exposure. Severe hepatic impairment increases the risk of bleeding because of reduced synthesis of coagulation proteins.Hitica Tab PrecautionsPrecautionDrugs that inhibit platelet function including Ticagrelor increase the risk of bleeding. If possible, manage bleeding without discontinuing Ticagrelor. Stopping Ticagrelor increases the risk of subsequent cardiovascular events.Hitica Tab WarningsWarning 1Patients treated with Ticagrelor may develop dyspnea. Dyspnea is usually mild to moderate in intensity and often resolves during continued treatment, but lead to drug discontinuation . If a patient develops new, prolonged, or worsened dyspnea that is determined to be related to Ticagrelor, no specific treatment is required; continue Ticagrelor without interruption if possible. In the case of intolerable dyspnea requiring discontinuation of Ticagrelor, consider prescribing another antiplatelet agent.Warning 2Discontinuation of Ticagrelor will increase the risk of myocardial infarction, stroke, and death. If Ticagrelor must be temporarily discontinued (e.g., to treat bleeding or for significant surgery), restart it as soon as possible. When possible, interrupt therapy with Ticagrelor for five days prior to surgery that has a major risk of bleeding. Resume Ticagrelor as soon as hemostasis is achieved.Warning 3Only limited information is available for use in patients with moderate hepatic impairment. Dose adjustments are not recommended but ticagrelor should be used with caution.Hitica Tab Additional InformationPregnancy categoryAlways consult your physician before using any medicine.Storage (YES/NO)Store this medicine at room temperature, away from direct light and heat.
Hitica Tab 90Mg 10S
₦618.00 -
Sale
?Hitone Bar?? Product Form:?Bar Pack Size:?75gmHitone bar 75g
Original price was: ₦293.00.₦263.00Current price is: ₦263.00. -
Sale
?Hitone Face Wash 150ml Product Form: Face Wash Pack Size: 125ml Manufactured By: Crystolite Pharmaceuticals Generic Category: Whitening Face WashHitone Face Wash 125ml
Original price was: ₦990.00.₦891.00Current price is: ₦891.00. -
Hitop Tablets SpecificationRequires Prescription (YES/NO)YesGenericsTopiramateUsed ForSeizures How it worksTopiramate works?by reducing the spread of seizure activity in the brain and restoring the normal balance of nerve activity. For epilepsy - brain cells normally talk to each other using electrical signals and chemicals. Seizures can happen when the brain cells are not working properly or working faster than normal.Hitop Tablets Usage And SafetyDosageTopiramateSide EffectsCommon (may affect up to 1 in 10 people) - Seizures (fits) , Anxiety, irritability, changes in mood, confusion, disorientation , Problems with concentration, slowness of thinking, loss of memory, problems with memory (new onset, sudden change or increased severity) , Kidney stone, frequent or painful urination.Uncommon (may affect up to 1 in 100 people) : Increased acid level in the blood (may cause troubled breathing including shortness of breath, loss of appetite, nausea, vomiting, excessive tiredness, and fast or uneven heart beats) , Decreased or loss of sweating (particularly in young children who are exposed to high temperatures) , Having thoughts of serious self-harm, trying to cause serious self-harm , Loss of part of the field of vision.Rare (may affect up to 1 in 1,000 people) : Glaucoma ? blockage of fluid in eye causing increased pressure in the eye, pain, or decreased vision , Difficulty thinking, remembering information, or solving problems, being less alert or aware, feeling , sleepy with low energy ? these symptoms may be a sign of a high level of ammonia in the blood (hyperammonemia), which can lead to a change in brain function (hyperammonemic encephalopathy).Drug Interactions Muscle relaxants and sedatives , risperidone, lithium, hydrochlorothiazide, metformin, pioglitazone, glibenclamide, amitriptyline, propranolol, diltiazem, venlafaxine, flunarazine, St. John's wort (Hypericum perforatum) (a herbal preparation used to treat depression), warfarin used to thin the blood.IndicationTopiramate belongs to a group of medicines called anti-epileptic medicines. Alone to treat seizures in adults and children over age 6 , with other medicines to treat seizures in adults and children aged 2 years and above - to prevent migraine headaches in adults .When not to UseDo not take Topiramate if: You are allergic to topiramate or any of the other ingredients of this medicine - for migraine prevention - if you are pregnant or if you are a woman of childbearing potential unless you are using effective contraception. You should talk to your doctor about the best kind of contraception to use while you are taking Topiramate.Hitop Tablets PrecautionsPrecautionYou may lose weight if you use Topiramate so your weight should be checked regularly when using this medicine. If you are losing too much weight or a child using this medicine is not gaining enough weight, you should consult your doctor.Hitop Tablets WarningsWarning 1It is important that you do not stop taking your medicine without first consulting your doctor.Warning 2A small number of people being treated with anti-epileptic medicines such as Topiramate have had thoughts of harming or killing themselves. If at any time you have these thoughts, immediately contact your doctor.Warning 3Topiramate can cause serious skin reactions, tell your doctor immediately if you develop a skin rash and/or blisters.Hitop Tablets Additional InformationPregnancy categoryAlways consult your physician before using any medicine.Storage (YES/NO)Store this medicine at room temperature, away from direct light and heat.
Hitop Tablets 100Mg (1 Strip = 10 Tablets)
₦5,331.00 -
Hitop Tablets SpecificationRequires Prescription (YES/NO)YesGenericsTopiramateUsed ForSeizures How it worksTopiramate works?by reducing the spread of seizure activity in the brain and restoring the normal balance of nerve activity. For epilepsy - brain cells normally talk to each other using electrical signals and chemicals. Seizures can happen when the brain cells are not working properly or working faster than normal.Hitop Tablets Usage And SafetyDosageTopiramateSide EffectsCommon (may affect up to 1 in 10 people) - Seizures (fits) , Anxiety, irritability, changes in mood, confusion, disorientation , Problems with concentration, slowness of thinking, loss of memory, problems with memory (new onset, sudden change or increased severity) , Kidney stone, frequent or painful urination.Uncommon (may affect up to 1 in 100 people) : Increased acid level in the blood (may cause troubled breathing including shortness of breath, loss of appetite, nausea, vomiting, excessive tiredness, and fast or uneven heart beats) , Decreased or loss of sweating (particularly in young children who are exposed to high temperatures) , Having thoughts of serious self-harm, trying to cause serious self-harm , Loss of part of the field of vision.Rare (may affect up to 1 in 1,000 people) : Glaucoma ? blockage of fluid in eye causing increased pressure in the eye, pain, or decreased vision , Difficulty thinking, remembering information, or solving problems, being less alert or aware, feeling , sleepy with low energy ? these symptoms may be a sign of a high level of ammonia in the blood (hyperammonemia), which can lead to a change in brain function (hyperammonemic encephalopathy).Drug Interactions Muscle relaxants and sedatives , risperidone, lithium, hydrochlorothiazide, metformin, pioglitazone, glibenclamide, amitriptyline, propranolol, diltiazem, venlafaxine, flunarazine, St. John's wort (Hypericum perforatum) (a herbal preparation used to treat depression), warfarin used to thin the blood.IndicationTopiramate belongs to a group of medicines called anti-epileptic medicines. Alone to treat seizures in adults and children over age 6 , with other medicines to treat seizures in adults and children aged 2 years and above - to prevent migraine headaches in adults .When not to UseDo not take Topiramate if: You are allergic to topiramate or any of the other ingredients of this medicine - for migraine prevention - if you are pregnant or if you are a woman of childbearing potential unless you are using effective contraception. You should talk to your doctor about the best kind of contraception to use while you are taking Topiramate.Hitop Tablets PrecautionsPrecautionYou may lose weight if you use Topiramate so your weight should be checked regularly when using this medicine. If you are losing too much weight or a child using this medicine is not gaining enough weight, you should consult your doctor.Hitop Tablets WarningsWarning 1It is important that you do not stop taking your medicine without first consulting your doctor.Warning 2A small number of people being treated with anti-epileptic medicines such as Topiramate have had thoughts of harming or killing themselves. If at any time you have these thoughts, immediately contact your doctor.Warning 3Topiramate can cause serious skin reactions, tell your doctor immediately if you develop a skin rash and/or blisters.Hitop Tablets Additional InformationPregnancy categoryAlways consult your physician before using any medicine.Storage (YES/NO)Store this medicine at room temperature, away from direct light and heat.
Hitop Tablets 25Mg (1 Strip = 10 Tablets)
₦3,009.00 -
Hitop Tablets SpecificationRequires Prescription (YES/NO)YesGenericsTopiramateUsed ForSeizures How it worksTopiramate works?by reducing the spread of seizure activity in the brain and restoring the normal balance of nerve activity. For epilepsy - brain cells normally talk to each other using electrical signals and chemicals. Seizures can happen when the brain cells are not working properly or working faster than normal.Hitop Tablets Usage And SafetyDosageTopiramateSide EffectsCommon (may affect up to 1 in 10 people) - Seizures (fits) , Anxiety, irritability, changes in mood, confusion, disorientation , Problems with concentration, slowness of thinking, loss of memory, problems with memory (new onset, sudden change or increased severity) , Kidney stone, frequent or painful urination.Uncommon (may affect up to 1 in 100 people) : Increased acid level in the blood (may cause troubled breathing including shortness of breath, loss of appetite, nausea, vomiting, excessive tiredness, and fast or uneven heart beats) , Decreased or loss of sweating (particularly in young children who are exposed to high temperatures) , Having thoughts of serious self-harm, trying to cause serious self-harm , Loss of part of the field of vision.Rare (may affect up to 1 in 1,000 people) : Glaucoma ? blockage of fluid in eye causing increased pressure in the eye, pain, or decreased vision , Difficulty thinking, remembering information, or solving problems, being less alert or aware, feeling , sleepy with low energy ? these symptoms may be a sign of a high level of ammonia in the blood (hyperammonemia), which can lead to a change in brain function (hyperammonemic encephalopathy).Drug Interactions Muscle relaxants and sedatives , risperidone, lithium, hydrochlorothiazide, metformin, pioglitazone, glibenclamide, amitriptyline, propranolol, diltiazem, venlafaxine, flunarazine, St. John's wort (Hypericum perforatum) (a herbal preparation used to treat depression), warfarin used to thin the blood.IndicationTopiramate belongs to a group of medicines called anti-epileptic medicines. Alone to treat seizures in adults and children over age 6 , with other medicines to treat seizures in adults and children aged 2 years and above - to prevent migraine headaches in adults .When not to UseDo not take Topiramate if: You are allergic to topiramate or any of the other ingredients of this medicine - for migraine prevention - if you are pregnant or if you are a woman of childbearing potential unless you are using effective contraception. You should talk to your doctor about the best kind of contraception to use while you are taking Topiramate.Hitop Tablets PrecautionsPrecautionYou may lose weight if you use Topiramate so your weight should be checked regularly when using this medicine. If you are losing too much weight or a child using this medicine is not gaining enough weight, you should consult your doctor.Hitop Tablets WarningsWarning 1It is important that you do not stop taking your medicine without first consulting your doctor.Warning 2A small number of people being treated with anti-epileptic medicines such as Topiramate have had thoughts of harming or killing themselves. If at any time you have these thoughts, immediately contact your doctor.Warning 3Topiramate can cause serious skin reactions, tell your doctor immediately if you develop a skin rash and/or blisters.Hitop Tablets Additional InformationPregnancy categoryAlways consult your physician before using any medicine.Storage (YES/NO)Store this medicine at room temperature, away from direct light and heat.
Hitop Tablets 50Mg (1 Strip = 10 Tablets)
₦4,259.00 -
HIV Rapid Test (Serum) (Cassette) direct binding screening test for the presence of antibodies to HIV1 and HIV2 viruses. Available at our branches country wide.HIV TEST CASSETTE (SINGLE TEST
₦100.00 -
Hivate Ointment SpecificationRequires Prescription (YES/NO)YesGenericsMometasone FuroateUsed ForPsoriasisHow it worksMometasone is one of a group of medicines called topical corticosteroids. Mometasone topical is classified as a ?potent corticosteroid?. These medicines are put on the surface of the skin to reduce the redness and itchiness caused by certain skin problems.Hivate Ointment Usage And SafetyDosageMometasone FuroateSide EffectsAllergic skin reactions - bacterial and secondary skin infections - acne - inflammation and/or infection of the hair follicles - thinning of the skin - red marks with associated prickly heat - loss of skin colour - burning - stinging - itching - tingling - excessive hair growth - softening of the skin and stretch marks - blurred vision . Drug InteractionsTell your doctor or pharmacist if you are using, have recently used or might use any other medicines. Pregnancy, breast-feeding and fertility.IndicationMometasone is used to reduce redness and itchiness caused by certain skin problems called psoriasis or dermatitis.When not to UseDo not use Mometasone topical if you are allergic (hypersensitive) to mometasone furoate, any of the other ingredients of Mometasone , or to similar medicines.Hivate Ointment PrecautionsPrecautionHyperglycaemia and glucosuria can occur in some patients after topical application due to systemic absorption.Hivate Ointment WarningsWarning 1If irritation or sensitisation develop with the use of Mometasone Furoate treatment should be withdrawn and appropriate therapy instituted.Warning 2Should an infection develop, use of an appropriate antifungal or antibacterial agent should be instituted. If a favourable response does not occur promptly, the corticosteroid should be discontinued until the infection is adequately controlled.Warning 3Topical steroids may be hazardous in psoriasis for a number of reasons including rebound relapses following development of tolerance, risk of centralised pustular psoriasis and development of local or systemic toxicity due to impaired barrier function of the skin. If used in psoriasis careful patient supervision is important.Hivate Ointment Additional InformationPregnancy categoryAlways consult your physician before using any medicine.Storage (YES/NO)Store this medicine at room temperature, away from direct light and heat.
Hivate Ointment 10G
₦2,724.00 -
Sale
